➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
AstraZeneca
Baxter
Express Scripts
Colorcon

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Details for Patent: 10,004,750

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 10,004,750 protect, and when does it expire?

Patent 10,004,750 protects FETROJA and is included in one NDA.

This patent has fifteen patent family members in twelve countries.

Summary for Patent: 10,004,750
Title:Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof
Abstract: The present invention provides an acid addition salt or a sodium salt of a compound represented by the formula (IA): ##STR00001## or their hydrate or a stable crystalline solid thereof. The salt or the crystalline solid is extremely useful as an active ingredient for the production of a pharmaceutical product.
Inventor(s): Matsubara; Fumihiko (Osaka, JP), Kurita; Takanori (Hyogo, JP), Nagamatsu; Daiki (Osaka, JP)
Assignee: Shionogi & Co., Ltd. (Osaka, JP)
Application Number:15/508,270
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Process;

Drugs Protected by US Patent 10,004,750

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Shionogi Inc FETROJA cefiderocol sulfate tosylate POWDER;INTRAVENOUS 209445-001 Nov 14, 2019 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,004,750

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2014-179853Sep 4, 2014
PCT Information
PCT FiledSeptember 03, 2015PCT Application Number:PCT/JP2015/075039
PCT Publication Date:March 10, 2016PCT Publication Number: WO2016/035845

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Medtronic
Harvard Business School
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.